
How Could Retatrutide Reshape Global Peptide API Demand After Phase III Success?
Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target…

Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target…

On May 21, Johnson & Johnson announced that its FcRn antagonist Imaavy® (nipocalimab injection) received…

In the global pharmaceutical supply chain, drug transportation is no longer a simple logistics process.…

Spinal muscular atrophy (SMA) has seen continuous advances in spinal muscular atrophy research, clinical treatment,…

On May 15, 2026, AbbVie announced that its CD20×CD3 bispecific antibody — Epkinly (Epcoritamab) —…

Key Takeaways Understand the overall system: Modern cancer treatment in China has developed into a…

A cancer diagnosis often brings many important questions.Which treatment option is most suitable? Which hospital…

Key Takeaways International Medical Services: More major Chinese hospitals have established international medical centers, with…

Since the beginning of 2026, the field of gastric cancer treatment has witnessed a major…

April 2026 marked another milestone for China innovative drug approvals April 2026, as the country…